E
EDWARDS LIFESCIENCES CORP
NYSE: EW (Edwards Lifesciences Corporatio)
Last update: 5 hours ago83.46
-0.89 (-1.06%)
| Previous Close | 84.35 |
| Open | 83.73 |
| Volume | 3,263,927 |
| Avg. Volume (3M) | 3,951,696 |
| Market Cap | 48,999,366,656 |
| Price / Earnings (TTM) | 36.61 |
| Price / Earnings (Forward) | 29.67 |
| Price / Sales | 8.43 |
| Price / Book | 4.80 |
| 52 Weeks Range | |
| Earnings Date | 10 Feb 2026 |
| Profit Margin | 75.71% |
| Operating Margin (TTM) | 29.01% |
| Diluted EPS (TTM) | 2.42 |
| Quarterly Revenue Growth (YOY) | 6.20% |
| Quarterly Earnings Growth (YOY) | 1.70% |
| Total Debt/Equity (MRQ) | 6.86% |
| Current Ratio (MRQ) | 4.45 |
| Operating Cash Flow (TTM) | 876.20 M |
| Levered Free Cash Flow (TTM) | 1.45 B |
| Return on Assets (TTM) | 8.42% |
| Return on Equity (TTM) | 16.51% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Edwards Lifesciences Corporatio | Bullish | Bullish |
AIStockmoo Score
-0.8
| Analyst Consensus | 5.0 |
| Insider Activity | -2.5 |
| Price Volatility | -3.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | -0.80 |
|
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Growth |
| % Held by Insiders | 0.91% |
| % Held by Institutions | 89.29% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Wellington Management Group Llp | 30 Sep 2025 | 20,804,416 |
| Jennison Associates Llc | 30 Sep 2025 | 13,958,774 |
| Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt | 30 Sep 2025 | 9,240,197 |
| Ninety One Uk Ltd | 30 Sep 2025 | 7,908,572 |
| Brown Advisory Inc | 30 Sep 2025 | 7,357,788 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 105.00 (Stifel, 25.81%) | Buy |
| Median | 98.00 (17.42%) | |
| Low | 87.00 (Canaccord Genuity, 4.24%) | Hold |
| 87.00 (Baird, 4.24%) | Hold | |
| Average | 97.41 (16.72%) | |
| Total | 13 Buy, 4 Hold | |
| Avg. Price @ Call | 84.26 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 12 Jan 2026 | 104.00 (24.61%) | Buy | 83.01 |
| 08 Dec 2025 | 103.00 (23.41%) | Buy | 84.32 | |
| UBS | 12 Jan 2026 | 95.00 (13.83%) | Hold | 83.01 |
| 05 Dec 2025 | 92.00 (10.23%) | Hold | 86.19 | |
| TD Cowen | 09 Jan 2026 | 97.00 (16.22%) | Buy | 85.13 |
| Stifel | 07 Jan 2026 | 105.00 (25.81%) | Buy | 84.83 |
| 05 Dec 2025 | 100.00 (19.82%) | Buy | 86.19 | |
| JP Morgan | 18 Dec 2025 | 100.00 (19.82%) | Buy | 84.80 |
| 31 Oct 2025 | 90.00 (7.84%) | Hold | 82.45 | |
| Canaccord Genuity | 17 Dec 2025 | 87.00 (4.24%) | Hold | 84.84 |
| 05 Dec 2025 | 89.00 (6.64%) | Hold | 86.19 | |
| Baird | 16 Dec 2025 | 87.00 (4.24%) | Hold | 85.32 |
| 05 Dec 2025 | 88.00 (5.44%) | Hold | 86.19 | |
| Citigroup | 11 Dec 2025 | 101.00 (21.02%) | Buy | 84.24 |
| 31 Oct 2025 | 96.00 (15.03%) | Buy | 82.45 | |
| BTIG | 05 Dec 2025 | 103.00 (23.41%) | Buy | 86.19 |
| 25 Nov 2025 | 100.00 (19.82%) | Buy | 86.82 | |
| RBC Capital | 05 Dec 2025 | 100.00 (19.82%) | Buy | 86.19 |
| 31 Oct 2025 | 95.00 (13.83%) | Buy | 82.45 | |
| Truist Securities | 05 Dec 2025 | 92.00 (10.23%) | Hold | 86.19 |
| 03 Nov 2025 | 90.00 (7.84%) | Hold | 83.07 | |
| Wells Fargo | 05 Dec 2025 | 96.00 (15.03%) | Buy | 86.19 |
| Evercore ISI Group | 31 Oct 2025 | 92.00 (10.23%) | Buy | 82.45 |
| Goldman Sachs | 31 Oct 2025 | 104.00 (24.61%) | Buy | 82.45 |
| Mizuho | 31 Oct 2025 | 100.00 (19.82%) | Buy | 82.45 |
| Piper Sandler | 31 Oct 2025 | 95.00 (13.83%) | Buy | 82.45 |
| Jefferies | 29 Oct 2025 | 98.00 (17.42%) | Buy | 82.69 |
| Show more | ||||
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BOBO DONALD E JR | - | 85.85 | -11,340 | -973,539 |
| LIPPIS DANIEL J. | - | 85.13 | -1,019 | -86,747 |
| Aggregate Net Quantity | -12,359 | |||
| Aggregate Net Value ($) | -1,060,286 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 85.49 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| LIPPIS DANIEL J. | Officer | 09 Jan 2026 | Automatic sell (-) | 1,019 | 85.13 | 86,747 |
| LIPPIS DANIEL J. | Officer | 09 Jan 2026 | Option execute | 1,019 | - | - |
| BOBO DONALD E JR | Officer | 06 Jan 2026 | Automatic sell (-) | 11,340 | 85.85 | 973,539 |
| BOBO DONALD E JR | Officer | 06 Jan 2026 | Option execute | 11,340 | - | - |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |